Trial Profile
Evaluation of Clevelox [clevidipine] in the postoperative treatment of hypertension assessing safety events (with nicardipine as active comparator) (ECLIPSE-NIC)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jun 2014
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary) ; Nicardipine
- Indications Cardiovascular disorders; Hypertension; Perioperative hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ECLIPSE-NIC
- Sponsors The Medicines Company
- 13 Sep 2006 Status change
- 08 Oct 2005 New trial record.